Development asset linked to Phathom Pharmaceuticals in public FDA and regional records.
pharma · H Pylori Infection · H. Pylori Infection · PHAT
Phathom Pharmaceuticals
Phathom Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
100 Campus Drive, Suite 102, Florham Park, New Jersey 07932, US HQ
2018 Founded
420 Employees
Public company Type
PHAT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932, US
- Founded
- 2018
- Employees
- 420
- Programs
- 11
- Drugs
- 5
- Patents
- 8
Phathom Pharmaceuticals pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Phathom Pharmaceuticals drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Phathom Pharmaceuticals in public FDA and regional records.
-
US regulatory status: approved.
-
US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
US regulatory status: approved. Molecular target: Potassium-transporting ATPase.
- Target
- Potassium-transporting ATPase
- Mechanism
- Potassium-transporting ATPase inhibitor